Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/3/23 16:17 | 3/1/23 | AXLA | Health | BioPrd | Biological Products, (No Diag | Koziel Margaret | MA | O | Chief Me | S | 0 | 0.5800 | 0 | -1 | -3 | 25 | D | ||||||||||||||
2/13/23 16:15 | 2/10/23 | AXLA | Health | BioPrd | Biological Products, (No Diag | Fehlner Paul | MA | O | SVP,GC | S | -3 | 0.6602 | 0 | -5 | -8 | 58 | D | ||||||||||||||
10/19/22 18:49 | 10/19/22 | AXLA | Health | BioPrd | Biological Products, (No Diag | Hinshaw William | MA | DO | P,CEO | S | -25 | 1.56 | 0 | -16 | -16 | 82 | D | ||||||||||||||
10/17/22 16:42 | 10/13/22 | AXLA | Health | BioPrd | Biological Products, (No Diag | Flagship Ventures Fund IV General Partner LLC | MA | T | P | 17,029 | 1.64 | 0 | 10,384 | 55 | 29,252 | I | |||||||||||||||
10/17/22 11:12 | 10/13/22 | AXLA | FdBev | Food | Food & Kindred Products | Societe Des Produits Nestle S.A. | V8 | T | P | 6,000 | 1.64 | 0 | 3,659 | 49 | 11,105 | I | |||||||||||||||
9/8/22 17:52 | 9/6/22 | AXLA | Health | BioPrd | Biological Products, (No Diag | Koziel Margaret | MA | O | Chief Me | S | -1 | 2.52 | 0 | -1 | -2 | 26 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |